Navigation Links
InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences
Date:6/6/2008

BRISBANE, Calif., June 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that John Hodgman, Senior Vice President and Chief Financial Officer of InterMune, will present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference in Dana Point, Calif. on June 10, 2008 at 8:05 a.m. PDT (11:05 a.m. EDT). Mr. Hodgman will also present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference in New York on June 12, 2008 at 9:30 a.m. EDT.

To access a live audio webcast of either presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentations in order to register or download any necessary software.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a pipeline portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone as a possible therapeutic candidate for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating a new target in hepatology. For additional information about InterMune and its R
'/>"/>

SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. InterMune to Present at Citigroup Healthcare Conference
2. InterMune to Present at Bank of America Health Care Conference
3. InterMune to Present at Deutsche Bank Health Care Conference
4. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
5. Evotec Expands Collaboration With InterMune
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
8. InterMune Announces Closing of Public Offering of Common Stock
9. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
10. InterMune Announces Proposed Public Offering of Common Stock
11. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Terascala, the industry leader in ... Swahn, a former vice president of product management for ... president of marketing. Terascala’s software when combined with leading ... the highest performance and most reliable solutions for processing ... Terascala’s channel expansion and broaden its product portfolio. His ...
(Date:7/10/2014)... Senior supply chain management executives from ... the challenges of “Reducing Cost, Lead Time, & Defects ... sourcing. Describing the partnership of the Bio Supply Management ... Institute ( SCMI) of the University of San ... the Kroc Institute of Peace and Justice in San ...
(Date:7/10/2014)... , July 10, 2014 Research and ... of the "International Photonic Integrated Circuit (Monolithic ... to 2019" report to their offering. ... The concept of photonic integration traces its roots ... The promise of photonic integration went unexplored and ...
(Date:7/10/2014)... study published today in the journal PNAS (Proceedings ... that time of day and sleep deprivation have a ... crucial when looking at the best time of day ... disease, and for administering medicines effectively. , Researchers from ... Research, London, investigated the links between sleep deprivation, body ...
Breaking Biology Technology:Terascala Expands Executive Team 2Terascala Expands Executive Team 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4International Photonic Integrated Circuit (Monolithic Integration, Hybrid Integration, Module Integration) Market - Forecasts to 2019 2Time of day crucial to accurately test for diseases, new research finds 2
... Oct. 27 In conjunction with DURECT Corporation,s (Nasdaq: ... press release, you are invited to listen to the ... internet on Wednesday, November 3, 2010 at 4:30 pm ...   http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ...
... Oct. 27 Regenicin, Inc. (OTC Bulletin Board: ... next-generation tissue-engineered skin substitutes to restore the qualities of ... Gervaise Gerstner to the company,s Scientific Advisory Board. Dr. ... of Dermatology at Mount Sinai Hospital in New York. ...
... ROCKVILLE, Md., Oct. 26 MacroGenics, Inc., a ... today that it has entered into a global ... to discover, develop and commercialize Dual-Affinity Re-Targeting (DART™) ... DART technology is a proprietary, bi-specific antibody platform ...
Cached Biology Technology:DURECT Corporation Invites You to Join its Third Quarter 2010 Earnings Conference Call 2Regenicin Appoints Renowned New York Dermatologist, Dr. Gervaise Gerstner to Scientific Advisory Board 2MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer 2MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer 3
(Date:7/10/2014)... 2014 Smart technology emphasis grows in ... improved security: NXT-ID, Inc. (OTCBB: NXTD), eBay Inc. (NASDAQ: ... Apple Inc. (NASDAQ: AAPL ), Visa Inc. (NYSE: ... NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication company focused on ... second series of 30 second spots on CNBC for its ...
(Date:7/10/2014)... July 2, 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric authentication ... Mr. Gino Pereira was interviewed on July 1 ... Tampa Florida . Mr. Pereira discusses the company,s ... Harris and how the Wocket™ aims to replace a ... Cedric Harris tells Gino he has never ...
(Date:7/10/2014)... July 7, 2014 Fingerprint Cards, (FPC,s) ... design win (DW). A Chinese Top 5 smartphone OEM has ... of mass production in October 2014.   FPC ... 5 smartphone OEM, which has a planned date for the ... sales volume for this phone of 3 million units. The ...
Breaking Biology News(10 mins):Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM 2
... create plastic floating islands containing papyrus plants to help ... Rift Valley, Kenya. The German REWE Group is ... and flower grower Finlays and Dr David Harper, a ... to recreate the water-cleansing services of papyrus as artificial ...
... researchers are among a select group of scientists from ... National Cancer Institute (NCI) for their quest to answer ... Professor and Chair of Oncological Sciences and Ross Cagan, ... received the NCI,s new "Provocative Questions" grant, which was ...
... the same when it comes to illness. In fact, the ... disease varies from one individual to another. A study led ... of the University of Geneva (UNIGE) reveals that the genetic ... to another depending on their sex. Together with his collaborators, ...
Cached Biology News:Novel plastic-and-papyrus restoration project 2Novel plastic-and-papyrus restoration project 3Mount Sinai researchers awarded 'Provocative Questions' grant from National Cancer Institute 2Mount Sinai researchers awarded 'Provocative Questions' grant from National Cancer Institute 3Men and women are different in terms of genetic predispositions 2
Mouse Iduronate 2-Sulfatase Affinity Purified Polyclonal Ab Keywords: Sulfatases, Iduronate 2-Sulfatase, Mucopolysaccharidosis, Hunter Syndrome, Glycobiology Protein Family: Proteoglycan Regu...
An instrument that delivers an accurate and uniform amount of light energy to cells to photoactivate csiRNA products....
interferon-related developmental regulator 2...
Human Serum FDA Licensed US Donor Centers Sterile / Non-sterile: Sterile Filtered to 0.2 micron Information: Extensive Viral Testing ...
Biology Products: